CorMedix Inc.

CRMD · NasdaqGM · Stock · Healthcare

$7.68

+3.86% today

Delayed price, 2026-10-15 15:23 UTC

What CorMedix does

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

Key facts

Sector

Healthcare

Industry

Biotechnology

Market cap

$598.2M

P/E (ttm)

3.7

Forward P/E

21.9

Dividend yield

0.00%

Beta

1.41

Profit margin

40.5%

Employees

191

Headquarters

Parsippany, NJ, United States

Exchange

NasdaqGM

Website

cormedix.com

Performance

1 Month

-0.6%

3 Months

-8.8%

6 Months

+3.9%

1 Year

-24.6%

5 Years

+54.1%

$6.1352-week range$13.02

Biggest setback — last 12 months

-50.1%

22 Dec 2025 → 16 Mar 2026

Fell from $12.53 to $6.25 — its sharpest sustained decline this year.

Biggest run-up — last 12 months

+40.0%

16 Mar 2026 → 29 Jun 2026

Ran from $6.25 to $8.75 — its strongest sustained advance this year.

Price outlook — trend & volatility model

● Trend: Below long-term trend

Price sits below its 200-day average, but the shorter-term averages are not cleanly aligned above/below it.

Horizon	Bear case (−1σ)	Base case	Bull case (+1σ)
1 Month	$6.50 (-15.3%)	$7.68	$9.06 (+18.1%)
3 Months	$5.76 (-25.0%)	$7.68	$10.23 (+33.3%)
6 Months	$5.11 (-33.4%)	$7.68	$11.53 (+50.2%)
12 Months	$4.32 (-43.7%)	$7.68	$13.64 (+77.7%)

Statistical, not machine-learning: a random-walk (no assumed drift) volatility model built from this ticker's own realized price history, plus a purely descriptive moving-average trend read. Illustrative only — not a price target and not financial advice. The bear and bull cases sit one standard deviation (1σ) below and above today's price, a range that covers about 68% of the outcomes the model treats as plausible, not a 68% chance of either case. Annualized volatility used: 57.5%, blended from this ticker's own 3-month and 1-year realized price history. Base case is deliberately flat — this quantifies a possible range, not a directional prediction. See the full model, including wider (≈95%) bands →

Comparable companies

COLL

Collegium Pharmaceutical, Inc.

$23.25 · +3.3%

LXRX

Lexicon Pharmaceuticals, Inc.

Phathom Pharmaceuticals, Inc.

$7.51 · +1.5%

AQST

Aquestive Therapeutics, Inc.

$4.32 · -6.4%

Recent headlines

CRMD vs. PRTA: Which Stock Should Value Investors Buy Now? — Zacks CorMedix (CRMD) Just Tripled Its Profits, But Guidance Barely Budged — Insider Monkey Wall Street Analysts Think CorMedix (CRMD) Could Surge 67.73%: Read This Before Placing a Bet — Zacks CorMedix (CRMD) Upgraded to Buy: Here's Why — Zacks CorMedix (CRMD) Q2 2026 Earnings Call Transcript — Motley Fool Wall Street Analysts Believe CorMedix (CRMD) Could Rally 65.96%: Here's is How to Trade — Zacks

Recent insider activity

Acquired 48,909 shares — Dillione Janet, Director · 2026-09-18

Sold 8,424 shares at $8.30 — Blum Susan, Chief Financial Officer · 2026-09-01

Sold 8,076 shares at $8.30 — Hurlburt Elizabeth, Chief Operating Officer · 2026-09-01

Sold 8,424 shares at $8.30 — Zelnick Kaufman Beth, Chief Legal Officer · 2026-09-01

Acquired 36,006 shares — Zelnick Kaufman Beth, Chief Legal Officer · 2026-02-06

Source: SEC Form 4 filings. An "acquired" entry with no price is typically a stock award or option exercise rather than an open-market purchase. Search all insider trades →

Learn the basics

What is a stock? Understanding risk and reward Why diversification matters

Prices and company data are delayed reference figures from public sources (Yahoo Finance, SEC EDGAR) and may be inaccurate or out of date. This page is informational only — it is not investment advice or a recommendation to buy or sell any security. Past performance does not indicate future results.